NCT00857350已完成不适用
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- HIV drug resistance
研究概览
简要总结
HIV drug resistance presents a significant public heath problem. This proposal is designed to explore the association between ongoing illicit drug use and the prevalence of HIV drug resistance among HIV+ opioid dependent patients receiving opioid agonist treatment with the following hypotheses:
- Hypothesis 1: The prevalence of HIV drug resistance will range between 10% and 30%.
- Hypothesis 2: Patients with evidence of ongoing illicit drug use will be more likely to have HIV drug resistance.
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Opioid dependent
- •Receiving methadone or buprenorphine for at least one month
排除标准
- •age < 18 years
- •current dementia;
- •inability to read or understand English
- •inability to provide written informed consent
结局指标
主要结局
HIV drug resistance
时间窗: Cross sectional
次要结局
- Illicit drug use(6 months)
- HIV transmission risk behaviors(1 year)
研究者
David Fiellin
Associate Professor of Medicine, Investigative Medicine and Public Health
Yale University
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Resistance in HIV+ in North and SouthHIV Drug ResistanceNCT02507921Infectious Diseases Institute2,750
已完成
2 期
The Multimedia HIV/STI Prevention for Drug-Involved Female OffendersHIVSexually Transmitted InfectionsNCT01784809Columbia University306
已完成
不适用
HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical OutcomesHIV InfectionMDR-TBNCT06671808Zahedan University of Medical Sciences222,128
招募中
不适用
HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in RussiaHIV-1-infectionNCT06127290Euresist Network GEIE200
Unknown
不适用
Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in TanzaniaHIV Drug ResistanceNCT03557021Medical Mission Institute, Germany1,250